Cargando…

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection

BACKGROUND: Prostate-specific antigen (PSA) is considered neither sensitive nor specific for prostate cancer (PCa). We aimed to compare total PSA (tPSA), percentage of free PSA (%fPSA), the PSA density (PSAD), Prostate Health Index (PHI), and the PHI density (PHID) to see which one could best predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Shih-Ting, Cheng, Yung-Ting, Pu, Yeong-Shiau, Lu, Yu-Chuan, Hong, Jian-Hua, Chung, Shiu-Dong, Chiang, Chih-Hung, Huang, Chao-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640459/ https://www.ncbi.nlm.nih.gov/pubmed/34869007 http://dx.doi.org/10.3389/fonc.2021.772182

Ejemplares similares

Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
por: Cheng, Yung-Ting, et al.
Publicado: (2020)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
por: Cheng, Yung-Ting, et al.
Publicado: (2022)

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
por: Barisiene, Marija, et al.
Publicado: (2020)

Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
por: Mo, Li-Cai, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study
por: Wu, Bo, et al.
Publicado: (2023)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer
por: Fan, Yu-Hua, et al.
Publicado: (2021)

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer
por: Chen, Yuanchong, et al.
Publicado: (2023)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Carbunaru, Samuel, et al.
Publicado: (2021)

Malakoplakia of the Prostate as a Mimicker of Prostate Cancer on Prostate Health Index and Magnetic Resonance Imaging–Fusion Prostate Biopsy: A Case Report
por: Heah, Nathaniel H., et al.
Publicado: (2017)

Assessment on clinical value of prostate health index in the diagnosis of prostate cancer
por: Zhang, Guangying, et al.
Publicado: (2019)

Prostate health index is useful for prostate cancer detecting in Chinese people
por: Huang, Yuhua, et al.
Publicado: (2019)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia
por: Kwon, Se Yun, et al.
Publicado: (2016)

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study
por: Lei, Yin, et al.
Publicado: (2022)

Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population
por: Hsieh, Po-Fan, et al.
Publicado: (2019)

Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma
por: Wang, Henry, et al.
Publicado: (2023)

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China
por: Huang, Da, et al.
Publicado: (2020)

Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer
por: Zhou, Yongheng, et al.
Publicado: (2022)

The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study
por: Wang, Shuo, et al.
Publicado: (2022)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience
por: Chiang, Bing-Juin, et al.
Publicado: (2013)

Primary Total Prostate Cryoablation for Localized High-Risk Prostate Cancer: 10-Year Outcomes and Nomograms
por: Chen, Chung-Hsin, et al.
Publicado: (2023)

The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
por: Gnanapragasam, V. J., et al.
Publicado: (2016)

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
por: Zhu, Yao, et al.
Publicado: (2015)

Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study
por: Park, Hongzoo, et al.
Publicado: (2018)

PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis
por: Akizhanova, Mariyam, et al.
Publicado: (2017)

USE OF THE PROSTATE HEALTH INDEX FOR DETECTION OF PROSTATE CANCER: RESULTS FROM A LARGE ACADEMIC PRACTICE
por: Tosoian, Jeffrey J., et al.
Publicado: (2017)

Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer
por: Hsieh, Po-Fan, et al.
Publicado: (2021)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
por: Lee, Chung-Un, et al.
Publicado: (2022)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
por: Kim, Jae Yeon, et al.
Publicado: (2023)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
por: Park, Hongzoo, et al.
Publicado: (2020)

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”
por: Zuccolotto, Gaia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvvua38i650fgpcsl8h325naik